000 | 01962 a2200541 4500 | ||
---|---|---|---|
005 | 20250516121624.0 | ||
264 | 0 | _c20131017 | |
008 | 201310s 0 0 eng d | ||
022 | _a1468-2060 | ||
024 | 7 |
_a10.1136/annrheumdis-2012-202275 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDistler, Alfiya | |
245 | 0 | 0 |
_aInactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling. _h[electronic resource] |
260 |
_bAnnals of the rheumatic diseases _cSep 2013 |
||
300 |
_a1575-80 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
650 | 0 | 4 |
_aCollagen _xmetabolism |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aFibroblasts _xdrug effects |
650 | 0 | 4 |
_aFibrosis _xdrug therapy |
650 | 0 | 4 |
_aGene Expression Regulation, Enzymologic _xdrug effects |
650 | 0 | 4 | _aGene Knockdown Techniques |
650 | 0 | 4 | _aGene Silencing |
650 | 0 | 4 |
_aGenes, myc _xdrug effects |
650 | 0 | 4 |
_aHeterocyclic Compounds, 3-Ring _xpharmacology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 |
_aMyofibroblasts _xdrug effects |
650 | 0 | 4 |
_aRNA, Small Interfering _xpharmacology |
650 | 0 | 4 |
_aScleroderma, Systemic _xdrug therapy |
650 | 0 | 4 |
_aSkin Diseases _xdrug therapy |
650 | 0 | 4 |
_aTankyrases _xantagonists & inhibitors |
650 | 0 | 4 |
_aWnt Signaling Pathway _xdrug effects |
700 | 1 | _aDeloch, Lisa | |
700 | 1 | _aHuang, Jingang | |
700 | 1 | _aDees, Clara | |
700 | 1 | _aLin, Neng-Yu | |
700 | 1 | _aPalumbo-Zerr, Katrin | |
700 | 1 | _aBeyer, Christian | |
700 | 1 | _aWeidemann, Alexander | |
700 | 1 | _aDistler, Oliver | |
700 | 1 | _aSchett, Georg | |
700 | 1 | _aDistler, Jörg H W | |
773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 72 _gno. 9 _gp. 1575-80 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/annrheumdis-2012-202275 _zAvailable from publisher's website |
999 |
_c22260542 _d22260542 |